Inorganic pyrophosphatase 1: a key player in immune and metabolic reprogramming in ankylosing spondylitis

Tianyou Chen,Chengqian Huang,Jiarui Chen,Jiang Xue,Zhenwei Yang,Yihan Wang,Songze Wu,Wendi Wei,Liyi Chen,Shian Liao,Xiaopeng Qin,Rongqing He,Boli Qin,Chong Liu
DOI: https://doi.org/10.1038/s41435-024-00308-0
2024-11-09
Genes and Immunity
Abstract:The relationships among immune cells, metabolites, and AS events were analyzed via Mendelian randomization (MR), and potential immune cells and metabolites were identified as risk factors for AS. Their relationships were subjected to intermediary MR analysis to identify the final immune cells and metabolites. The vertebral bone marrow blood samples from three patients with and without AS were subjected to 10× single-cell sequencing to further elucidate the role of immune cells in AS. The key genes were screened via expression quantitative trait loci (eQTLs) and MR analyses. The metabolic differences between the two groups were compared through single-cell metabolism analysis. Two subgroups of differentiated (CD)8+ memory T cells and naive B cells were obtained from the combined results of intermediary MR analysis and AS single-cell analysis. After the verification of key genes, inorganic pyrophosphatase 1 (PPA1) was identified as the hub gene, as it is differentially expressed in CD8+ memory T cells and can affect the metabolism of T cells in AS by affecting the expression of ferulic acid (FA)4 sulfate, which participates in the cellular immunity in AS.
genetics & heredity,immunology
What problem does this paper attempt to address?